144 related articles for article (PubMed ID: 38300220)
1. Translation of mechanistic advances in preeclampsia to the clinic: Long and winding road.
Thadhani R; Cerdeira AS; Karumanchi SA
FASEB J; 2024 Feb; 38(3):e23441. PubMed ID: 38300220
[TBL] [Abstract][Full Text] [Related]
2. Toward a new taxonomy of obstetrical disease: improved performance of maternal blood biomarkers for the great obstetrical syndromes when classified according to placental pathology.
Romero R; Jung E; Chaiworapongsa T; Erez O; Gudicha DW; Kim YM; Kim JS; Kim B; Kusanovic JP; Gotsch F; Taran AB; Yoon BH; Hassan SS; Hsu CD; Chaemsaithong P; Gomez-Lopez N; Yeo L; Kim CJ; Tarca AL
Am J Obstet Gynecol; 2022 Oct; 227(4):615.e1-615.e25. PubMed ID: 36180175
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanisms of preeclampsia.
Mutter WP; Karumanchi SA
Microvasc Res; 2008 Jan; 75(1):1-8. PubMed ID: 17553534
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in understanding of preeclampsia.
Bdolah Y; Karumanchi SA; Sachs BP
Croat Med J; 2005 Oct; 46(5):728-36. PubMed ID: 16158464
[TBL] [Abstract][Full Text] [Related]
5. Angiogenic factors in maternal circulation and preeclampsia with or without fetal growth restriction.
Vatten LJ; Åsvold BO; Eskild A
Acta Obstet Gynecol Scand; 2012 Dec; 91(12):1388-94. PubMed ID: 22882089
[TBL] [Abstract][Full Text] [Related]
6. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention.
Poon LC; Shennan A; Hyett JA; Kapur A; Hadar E; Divakar H; McAuliffe F; da Silva Costa F; von Dadelszen P; McIntyre HD; Kihara AB; Di Renzo GC; Romero R; D'Alton M; Berghella V; Nicolaides KH; Hod M
Int J Gynaecol Obstet; 2019 May; 145 Suppl 1(Suppl 1):1-33. PubMed ID: 31111484
[TBL] [Abstract][Full Text] [Related]
7. Associations Between Soluble fms-Like Tyrosine Kinase-1 and Placental Growth Factor and Disease Severity Among Women With Preterm Eclampsia and Preeclampsia.
Hastie R; Bergman L; Walker SP; Kaitu'u-Lino T; Hannan NJ; Brownfoot F; Schell S; Harper A; Cannon P; Cluver CA; Tong S
J Am Heart Assoc; 2022 Aug; 11(16):e024395. PubMed ID: 35943054
[TBL] [Abstract][Full Text] [Related]
8. Role of placental, fetal and maternal cardiovascular markers in predicting adverse outcome in women with suspected or confirmed pre-eclampsia.
Reddy M; Palmer K; Rolnik DL; Wallace EM; Mol BW; Da Silva Costa F
Ultrasound Obstet Gynecol; 2022 May; 59(5):596-605. PubMed ID: 34985800
[TBL] [Abstract][Full Text] [Related]
9. Angiogenic factors during pregnancy in Asian women with elevated blood pressure in early pregnancy and the risk of preeclampsia: a longitudinal cohort study.
Zhu J; Zhang J; Ng MJ; Chern B; Yeo GS; Tan KH
BMJ Open; 2019 Dec; 9(11):e032237. PubMed ID: 31791965
[TBL] [Abstract][Full Text] [Related]
10. The feasibility of soluble Fms-Like Tyrosine kinase-1 (sFLT-1) and Placental Growth Factor (PlGF) ratio biomarker in predicting preeclampsia and adverse pregnancy outcomes among medium to high risk mothers in Kuala Lumpur, Malaysia.
Aminuddin NA; Sutan R; Mahdy ZA; Rahman RA; Nasuruddin DN
PLoS One; 2022; 17(3):e0265080. PubMed ID: 35275947
[TBL] [Abstract][Full Text] [Related]
11. Placental Growth Factor Administration Abolishes Placental Ischemia-Induced Hypertension.
Spradley FT; Tan AY; Joo WS; Daniels G; Kussie P; Karumanchi SA; Granger JP
Hypertension; 2016 Apr; 67(4):740-7. PubMed ID: 26831193
[TBL] [Abstract][Full Text] [Related]
12. Affinity-Enhanced Multimeric VEGF (Vascular Endothelial Growth Factor) and PlGF (Placental Growth Factor) Variants for Specific Adsorption of sFlt-1 to Restore Angiogenic Balance in Preeclampsia.
Matin M; Mörgelin M; Stetefeld J; Schermer B; Brinkkoetter PT; Benzing T; Koch M; Hagmann H
Hypertension; 2020 Oct; 76(4):1176-1184. PubMed ID: 32623922
[TBL] [Abstract][Full Text] [Related]
13. Changes in circulating concentrations of soluble fms-like tyrosine kinase-1 and placental growth factor measured by automated electrochemiluminescence immunoassays methods are predictors of preeclampsia.
Leaños-Miranda A; Campos-Galicia I; Isordia-Salas I; Rivera-Leaños R; Romero-Arauz JF; Ayala-Méndez JA; Ulloa-Aguirre A
J Hypertens; 2012 Nov; 30(11):2173-81. PubMed ID: 22902831
[TBL] [Abstract][Full Text] [Related]
14. Multicenter prospective clinical study to evaluate the prediction of short-term outcome in pregnant women with suspected preeclampsia (PROGNOSIS): study protocol.
Hund M; Allegranza D; Schoedl M; Dilba P; Verhagen-Kamerbeek W; Stepan H
BMC Pregnancy Childbirth; 2014 Sep; 14():324. PubMed ID: 25230734
[TBL] [Abstract][Full Text] [Related]
15. Soluble fms-like tyrosine kinase 1 is increased in preeclampsia but not in normotensive pregnancies with small-for-gestational-age neonates: relationship to circulating placental growth factor.
Shibata E; Rajakumar A; Powers RW; Larkin RW; Gilmour C; Bodnar LM; Crombleholme WR; Ness RB; Roberts JM; Hubel CA
J Clin Endocrinol Metab; 2005 Aug; 90(8):4895-903. PubMed ID: 15886253
[TBL] [Abstract][Full Text] [Related]
16. Combining Biomarkers to Predict Pregnancy Complications and Redefine Preeclampsia: The Angiogenic-Placental Syndrome.
Stepan H; Hund M; Andraczek T
Hypertension; 2020 Apr; 75(4):918-926. PubMed ID: 32063058
[TBL] [Abstract][Full Text] [Related]
17. The soluble fms-like tyrosin kinase-1 (sFLT-1) to placental growth factor (PIGF) ratio as a possible indicator for the severity of preeclampsia - single institution experience.
Müller A; Horvat V; Vulin M; Mandić S; Šerić V; Vidosavljević D
Med Glas (Zenica); 2019 Feb; 16(1):53-59. PubMed ID: 30680983
[TBL] [Abstract][Full Text] [Related]
18. Pro-angiogenic therapeutics for preeclampsia.
Eddy AC; Bidwell GL; George EM
Biol Sex Differ; 2018 Aug; 9(1):36. PubMed ID: 30144822
[TBL] [Abstract][Full Text] [Related]
19. Clinical utility of sFlt-1 and PlGF in screening, prediction, diagnosis and monitoring of pre-eclampsia and fetal growth restriction.
Stepan H; Galindo A; Hund M; Schlembach D; Sillman J; Surbek D; Vatish M
Ultrasound Obstet Gynecol; 2023 Feb; 61(2):168-180. PubMed ID: 35816445
[TBL] [Abstract][Full Text] [Related]
20. [Potential value of placental angiogenic factors as biomarkers in preeclampsia for clinical physicians].
Boulanger H; Lefèvre G; Ahriz Saksi S; Achiche J; Bailleul S; Ekoukou D; Drouin D; Sault C; Stawiarski N; Dupuis E
Nephrol Ther; 2019 Nov; 15(6):413-429. PubMed ID: 30935786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
